16 Mar
The Organoid Centre at Hadassah Ein Kerem, the first of its kind in Israel, was established by Hadassah at the initiative of Prof. Eyal Mishani, head of Hadassah’s Research and Development Department and the Research Fund. The director is Dr. Myriam Grunewald, a specialist in vascular biology. Serving as director of the centre’s clinic is […]
READ MORE12 Jan
Classically, researchers in basic medical science have had two tools: in vitro cultures and animal models. The limitations pose many challenges: Cells taken out of the human body and grown in a petri dish won’t behave exactly as they do within a real organ of the body. Animal models are not as highly complex as the human body. […]
READ MORE17 Dec
A Phase 2 study at Hadassah Hospital Ein Kerem has revealed significant clinical improvements in patients with progressive multiple sclerosis (MS) after being treated with NG-01 stem cells developed by NeuroGenesis, a clinical-stage biopharmaceutical company advancing innovative cell therapies to combat neurodegenerative diseases. The 14-month randomized, double blind, placebo-controlled study, comprised of 48 patients, was led by Prof. […]
READ MORE10 Dec
Breaking news: The results of the latest M.S. research project study at Hadassah Hospitals in Jerusalem are just published in “Brain” Journal of Neurology by Oxford Academic. Hadassah UK is proud to have supported Multiple Sclerosis research at Hadassah by a team led by Prof. Dimitrios Karussis. Prof. Karussis’ team study is a culmination of […]
READ MORE6 Oct
From developing a melanoma vaccine to working on controlling diabetes, Hadassah’s multidisciplinary, collaborative approach is resulting in medical breakthroughs and innovations. Tens of thousands bless Travelan, the over-the-counter natural health product that helps prevent traveler’s diarrhea. The ultrasound device PainShield has wrought a revolution in healing chronic wounds. And PerioChip, inserted between tooth and gum, […]
READ MORE11 Mar
Written by Sarit Kleiman Synopsis Three weeks after the birth of their son, Arie Biton was diagnosed with M.S. A pioneering limited clinical trial for Israeli qualifying patients, using stem cells in Hadassah Ein Kerem is led by Prof. Dimitrios Karussis. This could help find a MS treatment and is missing $1 million. Sarit Kleiman […]
READ MOREHadassah UK © 2022 | w/creators with Web Studio Lab
Join our digital newsletter to stay in touch with the latest news from Hadassah UK